Clinical trial
An Open-label Trial of Metformin for Weight Control of Pediatric Patients on…
NCT00391261 · Cambridge Health Alliance, Other · Completed
Key facts
| NCT number | NCT00391261 |
|---|---|
| Title | An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. |
| Official title | A Prospective Open-label Trial of Metformin for Weight Control of Pediatric Patients on Atypical Antipsychotic Medications. |
| Lead sponsor | Cambridge Health Alliance, Other |
| Collaborators | American Psychiatric Association |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Bipolar Disorder, Autism Spectrum Disorders |
| Intervention type | Drug |
| Interventions | Metformin |
| Enrollment | 11 |
| Start date | Jul 1, 2006 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Oct 23, 2006 |
| Last update posted | Mar 25, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: